Dr. Paoluzzi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
777 Old Saw Mill River Rd
Tarrytown, NY 10591Phone+1 914-479-9389
Education & Training
NYU Grossman School of MedicineFellowship, Hematology and Medical Oncology, 2011 - 2015
Greenwich Hospital/Yale UniversityResidency, Internal Medicine, 2009 - 2011
Sapienza University of RomeClass of 1999
Certifications & Licensure
NY State Medical License 2015 - 2025- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 50 citationsPralatrexate is synergistic with the proteasome inhibitor bortezomib in in vitro and in vivo models of T-cell lymphoid malignancies.Enrica Marchi, Luca Paoluzzi, Luigi Scotto, Venkatraman E. Seshan, Jasmine Zain
Clinical Cancer Research. 2010-07-15 - 14 citationsThe novel kinesin spindle protein (KSP) inhibitor SB-743921 exhibits marked activity in in vivo and in vitro models of aggressive large B-cell lymphomaDanielle C Bongero, Luca Paoluzzi, Enrica Marchi, Kelly Zullo, Roberto Neisa
Leukemia & Lymphoma. 2015-04-10 - 87 citationsDiagnosis, Prognosis, and Treatment of Alveolar Soft-Part Sarcoma: A ReviewLuca Paoluzzi, Robert G. Maki
JAMA Oncology. 2019-02-01
Press Mentions
$111 Million NIH Grant Awarded to Consortium Conducted at Bronx Hospitals for HIV-Related ResearchSeptember 26th, 2020- $111 Million NIH Grant Awarded to Prevent and Treat HIV-Associated CancersSeptember 25th, 2020
- NCI Injects $111m into NYC’s Montefiore & Einstein to Prevent & Treat HIV-Associated CancersSeptember 24th, 2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
